✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹99 Cr.
P/E
3.52

Key Ratios

Market cap
Market cap
99.00 Cr
PE
PE
3.52
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
-13.06
ROCE (%)
ROCE (%)
-13.06
Div Yield (%)
Div Yield (%)
-
Sales
Sales
354 Cr
OPM (%)
OPM (%)
9.74 %
Debt to Equity
Debt to Equity
-
About
Welcure Drugs & Pharmaceuticals Ltd specializes in manufacturing and marketing a wide range of… Read more
Low
11
52W Range
High
12
  • Welcure Drugs&Pharma
  • Bhilwara Spinners
  • Prithvi Exchange (I)

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Welcure Drugs & Pharmaceuticals Ltd. Business

Welcure Drugs & Pharmaceuticals Ltd manufactures and markets over hundred varieties of pharmaceutical formulations including antibiotics, vitamins, and analgesics in tablets, capsules, and dry syrups.

Welcure Drugs&Pharma major competitors are Bhilwara Spinners, Prithvi Exchange (I), Chandrima Mercantile, Goyal Aluminiums, MRP Agro Ltd., Cravatex, Rajnish Retail.
Market Cap of Welcure Drugs&Pharma is ₹104 Crs.
While the median market cap of its peers are ₹108 Crs.

Welcure Drugs&Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Welcure Drugs&Pharma is 0 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Aug
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material